nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—ACE—umbilical vein—breast cancer	0.0185	0.175	CbGeAlD
Fosinopril—ACE—arm—breast cancer	0.0162	0.153	CbGeAlD
Fosinopril—SLC15A2—mammary gland—breast cancer	0.00616	0.0584	CbGeAlD
Fosinopril—SLC15A1—epithelium—breast cancer	0.00549	0.052	CbGeAlD
Fosinopril—SLC15A1—endometrium—breast cancer	0.00492	0.0466	CbGeAlD
Fosinopril—ACE—embryo—breast cancer	0.00482	0.0457	CbGeAlD
Fosinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—breast cancer	0.00452	0.0845	CbGpPWpGaD
Fosinopril—ACE—epithelium—breast cancer	0.00393	0.0373	CbGeAlD
Fosinopril—ACE—endometrium—breast cancer	0.00353	0.0334	CbGeAlD
Fosinopril—SLC15A1—endocrine gland—breast cancer	0.00345	0.0327	CbGeAlD
Fosinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—breast cancer	0.00328	0.0613	CbGpPWpGaD
Fosinopril—ACE—ACE Inhibitor Pathway—AGTR2—breast cancer	0.00327	0.061	CbGpPWpGaD
Fosinopril—ACE—pituitary gland—breast cancer	0.00319	0.0302	CbGeAlD
Fosinopril—ACE—adipose tissue—breast cancer	0.00318	0.0301	CbGeAlD
Fosinopril—SLC15A2—endometrium—breast cancer	0.00308	0.0291	CbGeAlD
Fosinopril—ACE—female reproductive system—breast cancer	0.00292	0.0277	CbGeAlD
Fosinopril—ACE—adrenal gland—breast cancer	0.00285	0.027	CbGeAlD
Fosinopril—SLC15A2—pituitary gland—breast cancer	0.00278	0.0264	CbGeAlD
Fosinopril—ACE—bone marrow—breast cancer	0.00276	0.0261	CbGeAlD
Fosinopril—ACE—female gonad—breast cancer	0.00266	0.0252	CbGeAlD
Fosinopril—SLC15A2—female reproductive system—breast cancer	0.00255	0.0241	CbGeAlD
Fosinopril—ACE—ACE Inhibitor Pathway—AGTR1—breast cancer	0.00251	0.0469	CbGpPWpGaD
Fosinopril—SLC15A2—adrenal gland—breast cancer	0.00249	0.0236	CbGeAlD
Fosinopril—ACE—endocrine gland—breast cancer	0.00247	0.0234	CbGeAlD
Fosinopril—SLC15A2—female gonad—breast cancer	0.00232	0.022	CbGeAlD
Fosinopril—SLC15A2—endocrine gland—breast cancer	0.00216	0.0204	CbGeAlD
Fosinopril—ACE—lymph node—breast cancer	0.00171	0.0162	CbGeAlD
Fosinopril—ACE—Peptide hormone metabolism—INHBB—breast cancer	0.00163	0.0304	CbGpPWpGaD
Fosinopril—Ramipril—BCHE—breast cancer	0.00158	0.406	CrCbGaD
Fosinopril—SLC15A2—lymph node—breast cancer	0.00149	0.0141	CbGeAlD
Fosinopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00148	0.0276	CbGpPWpGaD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00137	0.0256	CbGpPWpGaD
Fosinopril—ACE—ACE Inhibitor Pathway—NOS3—breast cancer	0.0013	0.0242	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—MME—breast cancer	0.00119	0.0222	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—ACHE—breast cancer	0.000912	0.017	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—CTSD—breast cancer	0.000863	0.0161	CbGpPWpGaD
Fosinopril—ACE—ACE Inhibitor Pathway—TGFB1—breast cancer	0.000858	0.016	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—BCHE—breast cancer	0.000794	0.0148	CbGpPWpGaD
Fosinopril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000761	0.0142	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—TCF7L2—breast cancer	0.000739	0.0138	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000723	0.0135	CbGpPWpGaD
Fosinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000706	0.0132	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000671	0.0125	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000661	0.0123	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000661	0.0123	CbGpPWpGaD
Fosinopril—Lisinopril—ABCB1—breast cancer	0.00064	0.164	CrCbGaD
Fosinopril—Cilazapril—ABCB1—breast cancer	0.00064	0.164	CrCbGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000613	0.0115	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000613	0.0115	CbGpPWpGaD
Fosinopril—Enalapril—CYP3A4—breast cancer	0.000564	0.145	CrCbGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000548	0.0102	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—IGFBP5—breast cancer	0.000535	0.00999	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000508	0.00949	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000501	0.00935	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—EEF1B2—breast cancer	0.000489	0.00913	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000482	0.009	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000482	0.009	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—LEP—breast cancer	0.000478	0.00892	CbGpPWpGaD
Fosinopril—Enalapril—ABCB1—breast cancer	0.00047	0.121	CrCbGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000465	0.00868	CbGpPWpGaD
Fosinopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000448	0.00837	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000448	0.00836	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000448	0.00836	CbGpPWpGaD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000416	0.00776	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000415	0.00775	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—IGF1—breast cancer	0.000395	0.00737	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000385	0.00719	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ATF4—breast cancer	0.000371	0.00692	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000367	0.00686	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000341	0.00636	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000336	0.00627	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000336	0.00627	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—EIF2S2—breast cancer	0.000334	0.00623	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000312	0.00582	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000312	0.00582	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—INHBB—breast cancer	0.000307	0.00574	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CCT5—breast cancer	0.000307	0.00574	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—CTNNB1—breast cancer	0.000293	0.00547	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—EEF2—breast cancer	0.000293	0.00547	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000278	0.0052	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000278	0.0052	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—RPL31—breast cancer	0.000275	0.00514	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000258	0.00482	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000258	0.00482	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—RPS4X—breast cancer	0.000257	0.0048	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000255	0.00475	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—DDIT3—breast cancer	0.000253	0.00472	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—EIF3A—breast cancer	0.000253	0.00472	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00025	0.00466	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ADAMTS1—breast cancer	0.000246	0.00458	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000245	0.00458	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000245	0.00458	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—MUC2—breast cancer	0.000239	0.00446	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000236	0.00441	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000232	0.00433	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000227	0.00425	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000227	0.00425	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PABPC1—breast cancer	0.000227	0.00424	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—MME—breast cancer	0.000225	0.00419	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—TUBB3—breast cancer	0.000222	0.00415	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000211	0.00394	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—RPL23A—breast cancer	0.000209	0.0039	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.0002	0.00374	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000196	0.00366	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—RPS7—breast cancer	0.000195	0.00364	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—RPS8—breast cancer	0.000195	0.00364	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000193	0.00361	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000193	0.0036	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000186	0.00347	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000179	0.00335	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000179	0.00335	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000179	0.00334	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—IGFBP3—breast cancer	0.000176	0.00329	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ACHE—breast cancer	0.000172	0.00322	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000166	0.00311	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CTSD—breast cancer	0.000163	0.00304	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—THBS1—breast cancer	0.000161	0.003	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000152	0.00285	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—BCHE—breast cancer	0.00015	0.0028	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—RPS6—breast cancer	0.000146	0.00273	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000142	0.00264	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—TCF7L2—breast cancer	0.00014	0.00261	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PLAUR—breast cancer	0.00013	0.00244	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PLG—breast cancer	0.000128	0.00238	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000127	0.00237	CbGpPWpGaD
Fosinopril—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000125	0.000149	CcSEcCtD
Fosinopril—Chills—Methotrexate—breast cancer	0.000125	0.000149	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000124	0.00232	CbGpPWpGaD
Fosinopril—Headache—Irinotecan—breast cancer	0.000124	0.000148	CcSEcCtD
Fosinopril—Headache—Mitoxantrone—breast cancer	0.000124	0.000148	CcSEcCtD
Fosinopril—Hypotension—Capecitabine—breast cancer	0.000124	0.000148	CcSEcCtD
Fosinopril—Insomnia—Docetaxel—breast cancer	0.000124	0.000148	CcSEcCtD
Fosinopril—Paraesthesia—Docetaxel—breast cancer	0.000123	0.000147	CcSEcCtD
Fosinopril—Erythema multiforme—Epirubicin—breast cancer	0.000123	0.000147	CcSEcCtD
Fosinopril—Vomiting—Gemcitabine—breast cancer	0.000123	0.000147	CcSEcCtD
Fosinopril—Bradycardia—Doxorubicin—breast cancer	0.000123	0.000146	CcSEcCtD
Fosinopril—Dyspnoea—Docetaxel—breast cancer	0.000122	0.000146	CcSEcCtD
Fosinopril—Somnolence—Docetaxel—breast cancer	0.000122	0.000146	CcSEcCtD
Fosinopril—Rash—Gemcitabine—breast cancer	0.000122	0.000145	CcSEcCtD
Fosinopril—Dermatitis—Gemcitabine—breast cancer	0.000122	0.000145	CcSEcCtD
Fosinopril—Tinnitus—Epirubicin—breast cancer	0.000121	0.000145	CcSEcCtD
Fosinopril—Haemoglobin—Doxorubicin—breast cancer	0.000121	0.000145	CcSEcCtD
Fosinopril—Headache—Gemcitabine—breast cancer	0.000121	0.000144	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000121	0.000144	CcSEcCtD
Fosinopril—Flushing—Epirubicin—breast cancer	0.000121	0.000144	CcSEcCtD
Fosinopril—Vomiting—Fluorouracil—breast cancer	0.000121	0.000144	CcSEcCtD
Fosinopril—Rhinitis—Doxorubicin—breast cancer	0.000121	0.000144	CcSEcCtD
Fosinopril—Dyspepsia—Docetaxel—breast cancer	0.000121	0.000144	CcSEcCtD
Fosinopril—Hepatitis—Doxorubicin—breast cancer	0.00012	0.000144	CcSEcCtD
Fosinopril—Haemorrhage—Doxorubicin—breast cancer	0.00012	0.000144	CcSEcCtD
Fosinopril—Insomnia—Capecitabine—breast cancer	0.00012	0.000143	CcSEcCtD
Fosinopril—Hypoaesthesia—Doxorubicin—breast cancer	0.00012	0.000143	CcSEcCtD
Fosinopril—Rash—Fluorouracil—breast cancer	0.00012	0.000143	CcSEcCtD
Fosinopril—Dermatitis—Fluorouracil—breast cancer	0.00012	0.000143	CcSEcCtD
Fosinopril—Pharyngitis—Doxorubicin—breast cancer	0.000119	0.000143	CcSEcCtD
Fosinopril—Paraesthesia—Capecitabine—breast cancer	0.000119	0.000142	CcSEcCtD
Fosinopril—Decreased appetite—Docetaxel—breast cancer	0.000119	0.000142	CcSEcCtD
Fosinopril—Hypersensitivity—Paclitaxel—breast cancer	0.000119	0.000142	CcSEcCtD
Fosinopril—Headache—Fluorouracil—breast cancer	0.000119	0.000142	CcSEcCtD
Fosinopril—Oedema peripheral—Doxorubicin—breast cancer	0.000119	0.000142	CcSEcCtD
Fosinopril—Dysgeusia—Methotrexate—breast cancer	0.000118	0.000142	CcSEcCtD
Fosinopril—Dyspnoea—Capecitabine—breast cancer	0.000118	0.000141	CcSEcCtD
Fosinopril—Fatigue—Docetaxel—breast cancer	0.000118	0.000141	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000118	0.0022	CbGpPWpGaD
Fosinopril—Nausea—Irinotecan—breast cancer	0.000118	0.000141	CcSEcCtD
Fosinopril—Nausea—Mitoxantrone—breast cancer	0.000118	0.000141	CcSEcCtD
Fosinopril—Constipation—Docetaxel—breast cancer	0.000117	0.00014	CcSEcCtD
Fosinopril—Pain—Docetaxel—breast cancer	0.000117	0.00014	CcSEcCtD
Fosinopril—Dyspepsia—Capecitabine—breast cancer	0.000117	0.000139	CcSEcCtD
Fosinopril—Chills—Epirubicin—breast cancer	0.000117	0.000139	CcSEcCtD
Fosinopril—Arrhythmia—Epirubicin—breast cancer	0.000116	0.000139	CcSEcCtD
Fosinopril—Visual impairment—Doxorubicin—breast cancer	0.000116	0.000139	CcSEcCtD
Fosinopril—Asthenia—Paclitaxel—breast cancer	0.000116	0.000139	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000115	0.00215	CbGpPWpGaD
Fosinopril—Decreased appetite—Capecitabine—breast cancer	0.000115	0.000138	CcSEcCtD
Fosinopril—Nausea—Gemcitabine—breast cancer	0.000115	0.000137	CcSEcCtD
Fosinopril—Fatigue—Capecitabine—breast cancer	0.000114	0.000137	CcSEcCtD
Fosinopril—Pruritus—Paclitaxel—breast cancer	0.000114	0.000137	CcSEcCtD
Fosinopril—Vision blurred—Methotrexate—breast cancer	0.000114	0.000136	CcSEcCtD
Fosinopril—Erythema multiforme—Doxorubicin—breast cancer	0.000114	0.000136	CcSEcCtD
Fosinopril—Pain—Capecitabine—breast cancer	0.000113	0.000136	CcSEcCtD
Fosinopril—Constipation—Capecitabine—breast cancer	0.000113	0.000136	CcSEcCtD
Fosinopril—Feeling abnormal—Docetaxel—breast cancer	0.000113	0.000135	CcSEcCtD
Fosinopril—Nausea—Fluorouracil—breast cancer	0.000113	0.000135	CcSEcCtD
Fosinopril—Ill-defined disorder—Methotrexate—breast cancer	0.000112	0.000134	CcSEcCtD
Fosinopril—Tinnitus—Doxorubicin—breast cancer	0.000112	0.000134	CcSEcCtD
Fosinopril—Gastrointestinal pain—Docetaxel—breast cancer	0.000112	0.000134	CcSEcCtD
Fosinopril—Anaemia—Methotrexate—breast cancer	0.000112	0.000134	CcSEcCtD
Fosinopril—Flushing—Doxorubicin—breast cancer	0.000112	0.000133	CcSEcCtD
Fosinopril—Flatulence—Epirubicin—breast cancer	0.000112	0.000133	CcSEcCtD
Fosinopril—Tension—Epirubicin—breast cancer	0.000111	0.000133	CcSEcCtD
Fosinopril—Dysgeusia—Epirubicin—breast cancer	0.000111	0.000132	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000111	0.00207	CbGpPWpGaD
Fosinopril—Diarrhoea—Paclitaxel—breast cancer	0.000111	0.000132	CcSEcCtD
Fosinopril—Nervousness—Epirubicin—breast cancer	0.00011	0.000131	CcSEcCtD
Fosinopril—Feeling abnormal—Capecitabine—breast cancer	0.000109	0.000131	CcSEcCtD
Fosinopril—Malaise—Methotrexate—breast cancer	0.000109	0.00013	CcSEcCtD
Fosinopril—Muscle spasms—Epirubicin—breast cancer	0.000109	0.00013	CcSEcCtD
Fosinopril—Vertigo—Methotrexate—breast cancer	0.000109	0.00013	CcSEcCtD
Fosinopril—Gastrointestinal pain—Capecitabine—breast cancer	0.000108	0.00013	CcSEcCtD
Fosinopril—Abdominal pain—Docetaxel—breast cancer	0.000108	0.000129	CcSEcCtD
Fosinopril—Body temperature increased—Docetaxel—breast cancer	0.000108	0.000129	CcSEcCtD
Fosinopril—Leukopenia—Methotrexate—breast cancer	0.000108	0.000129	CcSEcCtD
Fosinopril—Chills—Doxorubicin—breast cancer	0.000108	0.000129	CcSEcCtD
Fosinopril—Arrhythmia—Doxorubicin—breast cancer	0.000108	0.000128	CcSEcCtD
Fosinopril—Dizziness—Paclitaxel—breast cancer	0.000107	0.000128	CcSEcCtD
Fosinopril—Vision blurred—Epirubicin—breast cancer	0.000107	0.000127	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000107	0.00199	CbGpPWpGaD
Fosinopril—Cough—Methotrexate—breast cancer	0.000106	0.000126	CcSEcCtD
Fosinopril—Urticaria—Capecitabine—breast cancer	0.000105	0.000126	CcSEcCtD
Fosinopril—Ill-defined disorder—Epirubicin—breast cancer	0.000105	0.000126	CcSEcCtD
Fosinopril—Body temperature increased—Capecitabine—breast cancer	0.000105	0.000125	CcSEcCtD
Fosinopril—Abdominal pain—Capecitabine—breast cancer	0.000105	0.000125	CcSEcCtD
Fosinopril—Anaemia—Epirubicin—breast cancer	0.000105	0.000125	CcSEcCtD
Fosinopril—Agitation—Epirubicin—breast cancer	0.000104	0.000124	CcSEcCtD
Fosinopril—Flatulence—Doxorubicin—breast cancer	0.000103	0.000123	CcSEcCtD
Fosinopril—Chest pain—Methotrexate—breast cancer	0.000103	0.000123	CcSEcCtD
Fosinopril—Myalgia—Methotrexate—breast cancer	0.000103	0.000123	CcSEcCtD
Fosinopril—Arthralgia—Methotrexate—breast cancer	0.000103	0.000123	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000103	0.00192	CbGpPWpGaD
Fosinopril—Tension—Doxorubicin—breast cancer	0.000103	0.000123	CcSEcCtD
Fosinopril—Vomiting—Paclitaxel—breast cancer	0.000103	0.000123	CcSEcCtD
Fosinopril—Dysgeusia—Doxorubicin—breast cancer	0.000103	0.000123	CcSEcCtD
Fosinopril—Malaise—Epirubicin—breast cancer	0.000102	0.000122	CcSEcCtD
Fosinopril—Rash—Paclitaxel—breast cancer	0.000102	0.000122	CcSEcCtD
Fosinopril—Dermatitis—Paclitaxel—breast cancer	0.000102	0.000122	CcSEcCtD
Fosinopril—Discomfort—Methotrexate—breast cancer	0.000102	0.000122	CcSEcCtD
Fosinopril—Nervousness—Doxorubicin—breast cancer	0.000102	0.000122	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000102	0.0019	CbGpPWpGaD
Fosinopril—Vertigo—Epirubicin—breast cancer	0.000102	0.000122	CcSEcCtD
Fosinopril—Syncope—Epirubicin—breast cancer	0.000102	0.000121	CcSEcCtD
Fosinopril—Leukopenia—Epirubicin—breast cancer	0.000101	0.000121	CcSEcCtD
Fosinopril—Headache—Paclitaxel—breast cancer	0.000101	0.000121	CcSEcCtD
Fosinopril—Hypersensitivity—Docetaxel—breast cancer	0.000101	0.000121	CcSEcCtD
Fosinopril—Muscle spasms—Doxorubicin—breast cancer	0.000101	0.00012	CcSEcCtD
Fosinopril—Palpitations—Epirubicin—breast cancer	0.0001	0.00012	CcSEcCtD
Fosinopril—Confusional state—Methotrexate—breast cancer	9.96e-05	0.000119	CcSEcCtD
Fosinopril—Loss of consciousness—Epirubicin—breast cancer	9.95e-05	0.000119	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	9.9e-05	0.00185	CbGpPWpGaD
Fosinopril—Cough—Epirubicin—breast cancer	9.88e-05	0.000118	CcSEcCtD
Fosinopril—Anaphylactic shock—Methotrexate—breast cancer	9.87e-05	0.000118	CcSEcCtD
Fosinopril—Vision blurred—Doxorubicin—breast cancer	9.87e-05	0.000118	CcSEcCtD
Fosinopril—Asthenia—Docetaxel—breast cancer	9.83e-05	0.000117	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.83e-05	0.00183	CbGpPWpGaD
Fosinopril—Infection—Methotrexate—breast cancer	9.81e-05	0.000117	CcSEcCtD
Fosinopril—Hypertension—Epirubicin—breast cancer	9.78e-05	0.000117	CcSEcCtD
Fosinopril—Hypersensitivity—Capecitabine—breast cancer	9.77e-05	0.000117	CcSEcCtD
Fosinopril—Ill-defined disorder—Doxorubicin—breast cancer	9.72e-05	0.000116	CcSEcCtD
Fosinopril—Pruritus—Docetaxel—breast cancer	9.69e-05	0.000116	CcSEcCtD
Fosinopril—Anaemia—Doxorubicin—breast cancer	9.68e-05	0.000116	CcSEcCtD
Fosinopril—Thrombocytopenia—Methotrexate—breast cancer	9.67e-05	0.000116	CcSEcCtD
Fosinopril—Arthralgia—Epirubicin—breast cancer	9.64e-05	0.000115	CcSEcCtD
Fosinopril—Myalgia—Epirubicin—breast cancer	9.64e-05	0.000115	CcSEcCtD
Fosinopril—Chest pain—Epirubicin—breast cancer	9.64e-05	0.000115	CcSEcCtD
Fosinopril—Agitation—Doxorubicin—breast cancer	9.63e-05	0.000115	CcSEcCtD
Fosinopril—Nausea—Paclitaxel—breast cancer	9.6e-05	0.000115	CcSEcCtD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	9.55e-05	0.00178	CbGpPWpGaD
Fosinopril—Hyperhidrosis—Methotrexate—breast cancer	9.55e-05	0.000114	CcSEcCtD
Fosinopril—Discomfort—Epirubicin—breast cancer	9.52e-05	0.000114	CcSEcCtD
Fosinopril—Asthenia—Capecitabine—breast cancer	9.52e-05	0.000114	CcSEcCtD
Fosinopril—Malaise—Doxorubicin—breast cancer	9.45e-05	0.000113	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.44e-05	0.00176	CbGpPWpGaD
Fosinopril—Dry mouth—Epirubicin—breast cancer	9.43e-05	0.000113	CcSEcCtD
Fosinopril—Vertigo—Doxorubicin—breast cancer	9.41e-05	0.000112	CcSEcCtD
Fosinopril—Anorexia—Methotrexate—breast cancer	9.41e-05	0.000112	CcSEcCtD
Fosinopril—Syncope—Doxorubicin—breast cancer	9.4e-05	0.000112	CcSEcCtD
Fosinopril—Pruritus—Capecitabine—breast cancer	9.38e-05	0.000112	CcSEcCtD
Fosinopril—Leukopenia—Doxorubicin—breast cancer	9.38e-05	0.000112	CcSEcCtD
Fosinopril—Diarrhoea—Docetaxel—breast cancer	9.37e-05	0.000112	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—MMP1—breast cancer	9.33e-05	0.00174	CbGpPWpGaD
Fosinopril—Confusional state—Epirubicin—breast cancer	9.32e-05	0.000111	CcSEcCtD
Fosinopril—Palpitations—Doxorubicin—breast cancer	9.26e-05	0.000111	CcSEcCtD
Fosinopril—Oedema—Epirubicin—breast cancer	9.24e-05	0.00011	CcSEcCtD
Fosinopril—Anaphylactic shock—Epirubicin—breast cancer	9.24e-05	0.00011	CcSEcCtD
Fosinopril—Hypotension—Methotrexate—breast cancer	9.23e-05	0.00011	CcSEcCtD
Fosinopril—Loss of consciousness—Doxorubicin—breast cancer	9.21e-05	0.00011	CcSEcCtD
Fosinopril—Infection—Epirubicin—breast cancer	9.18e-05	0.00011	CcSEcCtD
Fosinopril—Cough—Doxorubicin—breast cancer	9.14e-05	0.000109	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.12e-05	0.0017	CbGpPWpGaD
Fosinopril—Shock—Epirubicin—breast cancer	9.09e-05	0.000109	CcSEcCtD
Fosinopril—Diarrhoea—Capecitabine—breast cancer	9.08e-05	0.000108	CcSEcCtD
Fosinopril—Dizziness—Docetaxel—breast cancer	9.06e-05	0.000108	CcSEcCtD
Fosinopril—Thrombocytopenia—Epirubicin—breast cancer	9.05e-05	0.000108	CcSEcCtD
Fosinopril—Hypertension—Doxorubicin—breast cancer	9.04e-05	0.000108	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—LEP—breast cancer	9.02e-05	0.00168	CbGpPWpGaD
Fosinopril—Tachycardia—Epirubicin—breast cancer	9.02e-05	0.000108	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Methotrexate—breast cancer	9e-05	0.000107	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	8.99e-05	0.00168	CbGpPWpGaD
Fosinopril—Hyperhidrosis—Epirubicin—breast cancer	8.93e-05	0.000107	CcSEcCtD
Fosinopril—Insomnia—Methotrexate—breast cancer	8.93e-05	0.000107	CcSEcCtD
Fosinopril—Myalgia—Doxorubicin—breast cancer	8.92e-05	0.000107	CcSEcCtD
Fosinopril—Chest pain—Doxorubicin—breast cancer	8.92e-05	0.000107	CcSEcCtD
Fosinopril—Arthralgia—Doxorubicin—breast cancer	8.92e-05	0.000107	CcSEcCtD
Fosinopril—Paraesthesia—Methotrexate—breast cancer	8.87e-05	0.000106	CcSEcCtD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	8.86e-05	0.00166	CbGpPWpGaD
Fosinopril—Discomfort—Doxorubicin—breast cancer	8.81e-05	0.000105	CcSEcCtD
Fosinopril—Anorexia—Epirubicin—breast cancer	8.81e-05	0.000105	CcSEcCtD
Fosinopril—Dyspnoea—Methotrexate—breast cancer	8.8e-05	0.000105	CcSEcCtD
Fosinopril—Somnolence—Methotrexate—breast cancer	8.78e-05	0.000105	CcSEcCtD
Fosinopril—Dizziness—Capecitabine—breast cancer	8.77e-05	0.000105	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	8.76e-05	0.00164	CbGpPWpGaD
Fosinopril—Dry mouth—Doxorubicin—breast cancer	8.72e-05	0.000104	CcSEcCtD
Fosinopril—Vomiting—Docetaxel—breast cancer	8.71e-05	0.000104	CcSEcCtD
Fosinopril—Dyspepsia—Methotrexate—breast cancer	8.69e-05	0.000104	CcSEcCtD
Fosinopril—Rash—Docetaxel—breast cancer	8.64e-05	0.000103	CcSEcCtD
Fosinopril—Hypotension—Epirubicin—breast cancer	8.63e-05	0.000103	CcSEcCtD
Fosinopril—Dermatitis—Docetaxel—breast cancer	8.63e-05	0.000103	CcSEcCtD
Fosinopril—Confusional state—Doxorubicin—breast cancer	8.62e-05	0.000103	CcSEcCtD
Fosinopril—Decreased appetite—Methotrexate—breast cancer	8.58e-05	0.000103	CcSEcCtD
Fosinopril—Headache—Docetaxel—breast cancer	8.58e-05	0.000103	CcSEcCtD
Fosinopril—Anaphylactic shock—Doxorubicin—breast cancer	8.55e-05	0.000102	CcSEcCtD
Fosinopril—Oedema—Doxorubicin—breast cancer	8.55e-05	0.000102	CcSEcCtD
Fosinopril—Fatigue—Methotrexate—breast cancer	8.51e-05	0.000102	CcSEcCtD
Fosinopril—Infection—Doxorubicin—breast cancer	8.49e-05	0.000101	CcSEcCtD
Fosinopril—Pain—Methotrexate—breast cancer	8.44e-05	0.000101	CcSEcCtD
Fosinopril—Vomiting—Capecitabine—breast cancer	8.43e-05	0.000101	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Epirubicin—breast cancer	8.42e-05	0.000101	CcSEcCtD
Fosinopril—Shock—Doxorubicin—breast cancer	8.41e-05	0.0001	CcSEcCtD
Fosinopril—Thrombocytopenia—Doxorubicin—breast cancer	8.37e-05	0.0001	CcSEcCtD
Fosinopril—Rash—Capecitabine—breast cancer	8.36e-05	9.99e-05	CcSEcCtD
Fosinopril—Insomnia—Epirubicin—breast cancer	8.36e-05	9.98e-05	CcSEcCtD
Fosinopril—Dermatitis—Capecitabine—breast cancer	8.36e-05	9.98e-05	CcSEcCtD
Fosinopril—Tachycardia—Doxorubicin—breast cancer	8.34e-05	9.97e-05	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	8.34e-05	0.00156	CbGpPWpGaD
Fosinopril—Headache—Capecitabine—breast cancer	8.31e-05	9.93e-05	CcSEcCtD
Fosinopril—Paraesthesia—Epirubicin—breast cancer	8.3e-05	9.91e-05	CcSEcCtD
Fosinopril—Hyperhidrosis—Doxorubicin—breast cancer	8.27e-05	9.87e-05	CcSEcCtD
Fosinopril—Dyspnoea—Epirubicin—breast cancer	8.24e-05	9.84e-05	CcSEcCtD
Fosinopril—Somnolence—Epirubicin—breast cancer	8.21e-05	9.81e-05	CcSEcCtD
Fosinopril—Anorexia—Doxorubicin—breast cancer	8.15e-05	9.74e-05	CcSEcCtD
Fosinopril—Nausea—Docetaxel—breast cancer	8.14e-05	9.72e-05	CcSEcCtD
Fosinopril—Feeling abnormal—Methotrexate—breast cancer	8.14e-05	9.72e-05	CcSEcCtD
Fosinopril—Dyspepsia—Epirubicin—breast cancer	8.13e-05	9.72e-05	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	8.13e-05	0.00152	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	8.08e-05	0.00151	CbGpPWpGaD
Fosinopril—Gastrointestinal pain—Methotrexate—breast cancer	8.07e-05	9.65e-05	CcSEcCtD
Fosinopril—Decreased appetite—Epirubicin—breast cancer	8.03e-05	9.6e-05	CcSEcCtD
Fosinopril—Hypotension—Doxorubicin—breast cancer	7.99e-05	9.54e-05	CcSEcCtD
Fosinopril—Fatigue—Epirubicin—breast cancer	7.97e-05	9.52e-05	CcSEcCtD
Fosinopril—Constipation—Epirubicin—breast cancer	7.9e-05	9.44e-05	CcSEcCtD
Fosinopril—Pain—Epirubicin—breast cancer	7.9e-05	9.44e-05	CcSEcCtD
Fosinopril—Nausea—Capecitabine—breast cancer	7.88e-05	9.41e-05	CcSEcCtD
Fosinopril—Urticaria—Methotrexate—breast cancer	7.84e-05	9.37e-05	CcSEcCtD
Fosinopril—Body temperature increased—Methotrexate—breast cancer	7.81e-05	9.33e-05	CcSEcCtD
Fosinopril—Abdominal pain—Methotrexate—breast cancer	7.81e-05	9.33e-05	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.79e-05	9.31e-05	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	7.76e-05	0.00145	CbGpPWpGaD
Fosinopril—Insomnia—Doxorubicin—breast cancer	7.73e-05	9.24e-05	CcSEcCtD
Fosinopril—Paraesthesia—Doxorubicin—breast cancer	7.68e-05	9.17e-05	CcSEcCtD
Fosinopril—Dyspnoea—Doxorubicin—breast cancer	7.62e-05	9.11e-05	CcSEcCtD
Fosinopril—Feeling abnormal—Epirubicin—breast cancer	7.61e-05	9.1e-05	CcSEcCtD
Fosinopril—Somnolence—Doxorubicin—breast cancer	7.6e-05	9.08e-05	CcSEcCtD
Fosinopril—Gastrointestinal pain—Epirubicin—breast cancer	7.56e-05	9.03e-05	CcSEcCtD
Fosinopril—Dyspepsia—Doxorubicin—breast cancer	7.53e-05	8.99e-05	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	7.5e-05	0.0014	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—IGF1—breast cancer	7.46e-05	0.00139	CbGpPWpGaD
Fosinopril—Decreased appetite—Doxorubicin—breast cancer	7.43e-05	8.88e-05	CcSEcCtD
Fosinopril—Fatigue—Doxorubicin—breast cancer	7.37e-05	8.81e-05	CcSEcCtD
Fosinopril—Urticaria—Epirubicin—breast cancer	7.34e-05	8.77e-05	CcSEcCtD
Fosinopril—Pain—Doxorubicin—breast cancer	7.31e-05	8.74e-05	CcSEcCtD
Fosinopril—Constipation—Doxorubicin—breast cancer	7.31e-05	8.74e-05	CcSEcCtD
Fosinopril—Abdominal pain—Epirubicin—breast cancer	7.3e-05	8.73e-05	CcSEcCtD
Fosinopril—Body temperature increased—Epirubicin—breast cancer	7.3e-05	8.73e-05	CcSEcCtD
Fosinopril—Hypersensitivity—Methotrexate—breast cancer	7.27e-05	8.69e-05	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—MMP2—breast cancer	7.22e-05	0.00135	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	7.2e-05	0.00134	CbGpPWpGaD
Fosinopril—Asthenia—Methotrexate—breast cancer	7.08e-05	8.46e-05	CcSEcCtD
Fosinopril—Feeling abnormal—Doxorubicin—breast cancer	7.05e-05	8.42e-05	CcSEcCtD
Fosinopril—Gastrointestinal pain—Doxorubicin—breast cancer	6.99e-05	8.35e-05	CcSEcCtD
Fosinopril—Pruritus—Methotrexate—breast cancer	6.99e-05	8.35e-05	CcSEcCtD
Fosinopril—Hypersensitivity—Epirubicin—breast cancer	6.81e-05	8.13e-05	CcSEcCtD
Fosinopril—Urticaria—Doxorubicin—breast cancer	6.79e-05	8.11e-05	CcSEcCtD
Fosinopril—Body temperature increased—Doxorubicin—breast cancer	6.76e-05	8.07e-05	CcSEcCtD
Fosinopril—Abdominal pain—Doxorubicin—breast cancer	6.76e-05	8.07e-05	CcSEcCtD
Fosinopril—Diarrhoea—Methotrexate—breast cancer	6.76e-05	8.07e-05	CcSEcCtD
Fosinopril—Asthenia—Epirubicin—breast cancer	6.63e-05	7.92e-05	CcSEcCtD
Fosinopril—Pruritus—Epirubicin—breast cancer	6.54e-05	7.81e-05	CcSEcCtD
Fosinopril—Dizziness—Methotrexate—breast cancer	6.53e-05	7.8e-05	CcSEcCtD
Fosinopril—Diarrhoea—Epirubicin—breast cancer	6.32e-05	7.55e-05	CcSEcCtD
Fosinopril—Hypersensitivity—Doxorubicin—breast cancer	6.3e-05	7.53e-05	CcSEcCtD
Fosinopril—Vomiting—Methotrexate—breast cancer	6.28e-05	7.5e-05	CcSEcCtD
Fosinopril—Rash—Methotrexate—breast cancer	6.23e-05	7.44e-05	CcSEcCtD
Fosinopril—Dermatitis—Methotrexate—breast cancer	6.22e-05	7.43e-05	CcSEcCtD
Fosinopril—Headache—Methotrexate—breast cancer	6.19e-05	7.39e-05	CcSEcCtD
Fosinopril—Asthenia—Doxorubicin—breast cancer	6.13e-05	7.33e-05	CcSEcCtD
Fosinopril—Dizziness—Epirubicin—breast cancer	6.11e-05	7.3e-05	CcSEcCtD
Fosinopril—Pruritus—Doxorubicin—breast cancer	6.05e-05	7.23e-05	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—CXCL8—breast cancer	6e-05	0.00112	CbGpPWpGaD
Fosinopril—Vomiting—Epirubicin—breast cancer	5.88e-05	7.02e-05	CcSEcCtD
Fosinopril—Nausea—Methotrexate—breast cancer	5.87e-05	7.01e-05	CcSEcCtD
Fosinopril—Diarrhoea—Doxorubicin—breast cancer	5.85e-05	6.99e-05	CcSEcCtD
Fosinopril—Rash—Epirubicin—breast cancer	5.83e-05	6.96e-05	CcSEcCtD
Fosinopril—Dermatitis—Epirubicin—breast cancer	5.82e-05	6.95e-05	CcSEcCtD
Fosinopril—Headache—Epirubicin—breast cancer	5.79e-05	6.92e-05	CcSEcCtD
Fosinopril—Dizziness—Doxorubicin—breast cancer	5.65e-05	6.75e-05	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—CTNNB1—breast cancer	5.53e-05	0.00103	CbGpPWpGaD
Fosinopril—Nausea—Epirubicin—breast cancer	5.49e-05	6.56e-05	CcSEcCtD
Fosinopril—Vomiting—Doxorubicin—breast cancer	5.44e-05	6.49e-05	CcSEcCtD
Fosinopril—Rash—Doxorubicin—breast cancer	5.39e-05	6.44e-05	CcSEcCtD
Fosinopril—Dermatitis—Doxorubicin—breast cancer	5.39e-05	6.43e-05	CcSEcCtD
Fosinopril—Headache—Doxorubicin—breast cancer	5.36e-05	6.4e-05	CcSEcCtD
Fosinopril—Nausea—Doxorubicin—breast cancer	5.08e-05	6.07e-05	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	4.85e-05	0.000906	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	4.5e-05	0.000841	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	4.39e-05	0.00082	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	4.07e-05	0.000761	CbGpPWpGaD
